Cidara Therapeutics and Melinta Therapeutics Announce FDA Advisory Committee Recommends Approval of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis
Stock Information for Cidara Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.